Hand-held confocal line-scanner for intrasurgical use

Information

  • Research Project
  • 6910652
  • ApplicationId
    6910652
  • Core Project Number
    R44CA093106
  • Full Project Number
    5R44CA093106-04
  • Serial Number
    93106
  • FOA Number
    PAR-01-102
  • Sub Project Id
  • Project Start Date
    9/14/2001 - 23 years ago
  • Project End Date
    6/30/2007 - 17 years ago
  • Program Officer Name
    FARAHANI, KEYVAN
  • Budget Start Date
    8/12/2005 - 19 years ago
  • Budget End Date
    6/30/2007 - 17 years ago
  • Fiscal Year
    2005
  • Support Year
    4
  • Suffix
  • Award Notice Date
    8/12/2005 - 19 years ago
Organizations

Hand-held confocal line-scanner for intrasurgical use

DESCRIPTION (provided by applicant): Design of a laboratory prototype, product development and clinical testing of a real-time hand-held confocal line-scanner is proposed for imaging-guided microsurgery applications. Line scanning offers resolution, contrast and field of view that are required for intrasurgical imaging. In the Phase I feasibility project, the laboratory prototype successfully demonstrated imaging of nuclear and cellular detail in human epidermis in vivo with 5-10 microns resolution. In Phase II, the goals are to quantitatively characterize optical performance within living human skin, package the prototype into a hand-held confocal scanner product, and test the scanner for imaging basal cell cancers on patients during Mohs surgery. Vis-a-vis the current method based on frozen pathology, real-time in situ confocal imaging may save both Mohs surgeon and patient several hours in the operating room. The hand-held line-scanning confocal microscope will have everything that surgeons and patients want: simple and robust design, inexpensive ($10K-20K), user-friendly package, controls and interface, and standard detection and display systems. The first application is for skin cancer but other tissues will be subsequently imaged as well. The intended users are surgeons, and the potential benefits to the patient are: painless, fast, less expensive and therefore significantly improved healthcare.

IC Name
NATIONAL CANCER INSTITUTE
  • Activity
    R44
  • Administering IC
    CA
  • Application Type
    5
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    786943
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    394
  • Ed Inst. Type
  • Funding ICs
    NCI:786943\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    LUCID, INC.
  • Organization Department
  • Organization DUNS
    795857648
  • Organization City
    ROCHESTER
  • Organization State
    NY
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    14623
  • Organization District
    UNITED STATES